Development of Novel Promiscuous Anti-Chemokine Peptibodies for Treating Autoimmunity and Inflammation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development of Novel Promiscuous Anti-Chemokine Peptibodies for Treating Autoimmunity and Inflammation

Published:2017-11-23 Issue: Volume:8 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Abraham Michal,Wald Hanna,Vaizel-Ohayon Dalit,Grabovsky Valentin,Oren Zohar,Karni Arnon,Weiss Lola,Galun Eithan,Peled Amnon,Eizenberg Orly

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference54 articles.

1. CC chemokines in allergic inflammation;Baggiolini;Immunol Today,1994

2. Regulation of monocyte integrin expression by beta-family chemokines;Vaddi;J Immunol,1994

3. Chemokines and chemokine receptors: positioning cells for host defense and immunity;Griffith;Annu Rev Immunol,2014

4. Promiscuous drugs as therapeutics for chemokine receptors;Horuk;Expert Rev Mol Med,2009

5. Chemokine receptor antagonists: overcoming developmental hurdles;Horuk;Nat Rev Drug Discov,2009

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bromelain-loaded nanocomposites decrease inflammatory and cytotoxicity effects of gliadin on Caco-2 cells and peripheral blood mononuclear cells of celiac patients;Scientific Reports;2023-12-01

2. Role of MCP-1/CCR2 axis in renal fibrosis: Mechanisms and therapeutic targeting;Medicine;2023-10-20

3. Discovery and pharmacophoric characterization of chemokine network inhibitors using phage-display, saturation mutagenesis and computational modelling;Nature Communications;2023-09-16

4. Potential utility of urinary chemokine CCL2 to creatinine ratio in prognosis of 5‐year graft failure and mortality post 1‐year protocol biopsy in kidney transplant recipients;Immunity, Inflammation and Disease;2023-06

5. The Screening of Therapeutic Peptides for Anti-Inflammation through Phage Display Technology;International Journal of Molecular Sciences;2022-08-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3